Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO1992010180) USE OF ANGIOTENSIN II ANTAGONIST IN THE TREATMENT OF INFARCTION
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1992/010180 International Application No.: PCT/GB1991/002218
Publication Date: 25.06.1992 International Filing Date: 12.12.1991
Chapter 2 Demand Filed: 28.05.1992
IPC:
A61K 31/41 (2006.01) ,A61K 31/415 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
415
1,2-Diazoles
Applicants:
SMITHKLINE BEECHAM PLC [GB/GB]; New Horizons Court Brentford Middlesex TW8 9EP, GB (AllExceptUS)
HILL, James [GB/GB]; GB (UsOnly)
Inventors:
HILL, James; GB
Agent:
THOMPSON, Clive, B.; Corporate Patents SmithKline Beecham Mundells Welwyn Garden City Hertfordshire AL7 1EY, GB
Priority Data:
9027208.914.12.1990GB
Title (EN) USE OF ANGIOTENSIN II ANTAGONIST IN THE TREATMENT OF INFARCTION
(FR) UTILISATION D'ANTAGONISTE DE L'ANGIOTENSINE II DANS LE TRAITEMENT DES INFARCTUS
Abstract:
(EN) The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for primary and secondary prevention of infarction.
(FR) L'invention se rapporte à l'utilisation d'un agent, antagoniste du récepteur de l'angiotensine II dans la fabrication d'un médicament destiné à la prévention primaire et secondaire des infarctus.
Designated States: AU, CA, JP, KR, US
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, MC, NL, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0561878US20010034360US20020068759US20020160985US20030069293JPH06503322
AU1991090529